Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy.

Zammarchi L, Montagnani F, Tordini G, Gotuzzo E, Bisoffi Z, Bartoloni A, De Luca A.

Am J Trop Med Hyg. 2015 Jun;92(6):1257-60. doi: 10.4269/ajtmh.14-0716. Epub 2015 Apr 6.

2.

Five cases of recurrent meningitis associated with chronic strongyloidiasis.

Shimasaki T, Chung H, Shiiki S.

Am J Trop Med Hyg. 2015 Mar;92(3):601-4. doi: 10.4269/ajtmh.14-0564. Epub 2014 Dec 29.

3.

Bacteroides-associated pylephlebitis in a patient with strongyloidiasis.

Stone NR, Martin T, Biswas J, Barrett J, Hickish T, Dasgupta D, Newsholme W.

Am J Trop Med Hyg. 2015 Feb;92(2):340-1. doi: 10.4269/ajtmh.14-0294. Epub 2014 Dec 15.

4.

Strongyloidiasis hyperinfection in a patient with a history of systemic lupus erythematosus.

Yung EE, Lee CM, Boys J, Grabo DJ, Buxbaum JL, Chandrasoma PT.

Am J Trop Med Hyg. 2014 Oct;91(4):806-9. doi: 10.4269/ajtmh.14-0228. Epub 2014 Aug 4.

5.

Strongyloidiasis: an emerging infectious disease in China.

Wang C, Xu J, Zhou X, Li J, Yan G, James AA, Chen X.

Am J Trop Med Hyg. 2013 Mar;88(3):420-5. doi: 10.4269/ajtmh.12-0596. Review.

6.

Non-oral treatment with ivermectin for disseminated strongyloidiasis.

Fusco DN, Downs JA, Satlin MJ, Pahuja M, Ramos L, Barie PS, Fleckenstein L, Murray HW.

Am J Trop Med Hyg. 2010 Oct;83(4):879-83. doi: 10.4269/ajtmh.2010.10-0258.

7.

Strongyloidiasis-related deaths in the United States, 1991-2006.

Croker C, Reporter R, Redelings M, Mascola L.

Am J Trop Med Hyg. 2010 Aug;83(2):422-6. doi: 10.4269/ajtmh.2010.09-0750.

8.

Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful?

Biggs BA, Caruana S, Mihrshahi S, Jolley D, Leydon J, Chea L, Nuon S.

Am J Trop Med Hyg. 2009 May;80(5):788-91.

9.

Invasive enteric infections in hospitalized patients with underlying strongyloidiasis.

Al-Hasan MN, McCormick M, Ribes JA.

Am J Clin Pathol. 2007 Oct;128(4):622-7.

10.

Seroepidemiology of strongyloidiasis in the Peruvian Amazon.

Yori PP, Kosek M, Gilman RH, Cordova J, Bern C, Chavez CB, Olortegui MP, Montalvan C, Sanchez GM, Worthen B, Worthen J, Leung F, Oré CV.

Am J Trop Med Hyg. 2006 Jan;74(1):97-102.

11.

Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.

Turner SA, Maclean JD, Fleckenstein L, Greenaway C.

Am J Trop Med Hyg. 2005 Nov;73(5):911-4.

12.

Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.

Porto MA, Alcântara LM, Leal M, Castro N, Carvalho EM.

Am J Trop Med Hyg. 2005 Feb;72(2):124-5.

13.

Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration.

Lanzafame M, Faggian F, Lattuada E, Antolini D, Vento S.

J Infect Dis. 2005 Mar 15;191(6):1027. No abstract available.

14.

Why does HIV infection not lead to disseminated strongyloidiasis?

Viney ME, Brown M, Omoding NE, Bailey JW, Gardner MP, Roberts E, Morgan D, Elliott AM, Whitworth JA.

J Infect Dis. 2004 Dec 15;190(12):2175-80. Epub 2004 Nov 16.

15.
16.

Strongyloidiasis in patients at a comprehensive cancer center in the United States.

Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KV.

Cancer. 2004 Apr 1;100(7):1531-6.

17.

Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area.

Loutfy MR, Wilson M, Keystone JS, Kain KC.

Am J Trop Med Hyg. 2002 Jun;66(6):749-52.

18.

Case study: Fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection.

Adedayo AO, Grell GA, Bellot P.

Am J Trop Med Hyg. 2001 Nov;65(5):650-1.

19.

Influence of human T-cell lymphocytotropic virus type 1 infection on serologic and skin tests for strongyloidiasis.

Porto AF, Oliveira Filho J, Neva FA, Orge G, Alcântara L, Gam A, Carvalho EM.

Am J Trop Med Hyg. 2001 Nov;65(5):610-3.

20.

The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies.

Schaffel R, Nucci M, Carvalho E, Braga M, Almeida L, Portugal R, Pulcheri W.

Am J Trop Med Hyg. 2001 Oct;65(4):346-50.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk